1 paper
Donghoon Kim, Jon Andre Ottesen, Ashwin Kumar +5
Identifying amyloid-beta positive patients is crucial for determining eligibility for Alzheimer's disease (AD) clinical trials and new disease-modifying treatments, but currently r…